20th International Congress » Surgical therapy: Parkinson's disease

Date: Monday, June 20, 2016

Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Session Type: Poster Session

Meeting: 20th International Congress

12:30pm-2:00pm: “Two odd targets” strategy in deep brain stimulation for Parkinson’s disease with unilateral dystonia

S. Sekimoto, G. Oyama, T. Jo, A. Nakajima, Y. Shimo, M. Nakajima, A. Umemura, M. Ito, H. Arai, N. Hattori (Bunkyo-ku, Japan)

12:30pm-2:00pm: A case of thalamic malignant glioma formation in a patient with STN-DBS for Parkinson’s disease

A. Tomskiy, A. Gamaleya, N. Gubareva, Y. Latyshev, G. Kobyakov, L. Shishkina, I. Pronin (Moscow, Russia)

12:30pm-2:00pm: A cognitive monitoring program for individuals with Parkinson’s disease submitted to deep brain stimulation

L. Fontão, R. Barreto, L. Ruano, A. Sousa, A.I. Martins, A. Costa, A. Aires, C. Sousa, J. Lima, J. Pais, M.J. Rosas, R. Vaz, V.T. Cruz (Santa Maria da Feira, Portugal)

12:30pm-2:00pm: A dopamine-dependent activity of the STN in the control of balance in Parkinson’s disease

G. Arnulfo, N.G. Pozzi, C. Palmisano, A. Canessa, J. Brumberg, C.A. Frigo, G. Pezzoli, F. Steigerwald, J. Volkmann, I.U. Isaias (Würzburg, Germany)

12:30pm-2:00pm: A multi-site survey of Parkinson’s disease deep brain stimulation center best practice: moving toward a standard of care for DBS

A.A. Butala, K.A. Mills, P. Schmidt, M.S. Okun, Z. Mari (Baltimore, MD, USA)

12:30pm-2:00pm: A pilot study of horizontal current steering with chronically implanted segmented electrodes for STN-DBS in Parkinson’s disease

F. Steigerwald, L. Mueller, S. Johannes, C. Matthies, J. Volkmann (Würzburg, Germany)

12:30pm-2:00pm: A prospective study of patients’ expectations in subthalamic nucleus deep brain stimulation for Parkinson’s disease

N.R. Mundil, H.Y. Ling, H. Hasegawa, M. Samuel, K. Ashkan (London, United Kingdom)

12:30pm-2:00pm: Accuracy of intraoperative CT during DBS procedures: Comparison with postoperative MRI

L. Verhagen Metman, P. van den Munckhof, R. Bakay, G. Stebbins, M. Bot (Chicago, IL, USA)

12:30pm-2:00pm: Airway protective mechanisms and deep brain stimulation in Parkinson’s disease

M.S. Troche, A.E. Brandimore, K.W. Hegland, P.W. Davenport, K.F. Foote, M.S. Okun (New York, NY, USA)

12:30pm-2:00pm: AntiParkinsonian medication adjustments following deep brain stimulation of subthalamic nucleus in patients with advanced Parkinson’s disease

A. Gamaleya, E. Bril, A. Tomskiy, A. Poddubskaya, N. Gubareva, N. Fedorova, V. Shabalov (Moscow, Russia)

12:30pm-2:00pm: Assessment of freezing of gait in Parkinson’s disease patients treated with STN-DBS

K. Peterova, E. Ruzicka, R. Jech, J. Rusz, E. Plananská, L. Brabcová, H. Brozová (Prague, Czech Republic)

12:30pm-2:00pm: Bilateral subthalamic nucleus deep-brain stimulation (STN-DBS) in the management of idiopathic Parkinson’s disease: Results of our first 20 cases

E.M. Rezk, A.A.E. Shakal, S.M. Tourky (Tanta-Gharbeya, Egypt)

12:30pm-2:00pm: Can a leopard changes its spots? How impulse control disorder affects subthalamic stimulation paradigm

N.G. Pozzi, B. Minafra, M. Picascia, R. Zangaglia, D. Servello, C. Pacchetti (Pavia, Italy)

12:30pm-2:00pm: Can intraoperative clinical testing really predict the effects of deep brain stimulation in the subthalamic nucleus?

J. Blume, J. Schlaier, F. Zeman, E. Rothenfußer, A. Brawanski, U. Bogdahn, M. Lange (Regensburg, Germany)

12:30pm-2:00pm: Can stimulation of deep brain tissue improve the expression of the mouth in Parkinson’s disease patients?

M.V. Alvarez, P.M. Grogan (San Antonio, TX, USA)

12:30pm-2:00pm: Changes in mood and behavior following DBS – Measurement by self-reported questionaires

I. Galazky, S. Hubich, T. Zähle, J. Voges (Magdeburg, Germany)

12:30pm-2:00pm: Chronic directional subthalamic nucleus deep brain stimulation in Parkinson’s disease – A pilot study

P. Reker, T.A. Dembek, A. Gierich, J. Wirths, H.S. Dafsari, J. Roediger, M.T. Barbe, L. Timmermann, V. Visser-Vandewalle (Cologne, Germany)

12:30pm-2:00pm: Clinical characteristics of Parkinson’s disease and essential tremor patients undergoing deep brain stimulation surgery: Five-year data from Columbia University Medical Center (2009 – 2014)

M. Kestenbaum, D. Robakis, B. Ford, R.N. Alcalay, E.D. Louis (Tel Aviv, Israel)

12:30pm-2:00pm: Clinical outcome of subthalamic deep brain stimulation in Parkinson’s disease – The Helsinki experience

M. Koivu, A. Huotarinen, F. Scheperjans, R. Kivisaari, E. Pekkonen (Helsinki, Finland)

12:30pm-2:00pm: Cognitive change following deep brain stimulation in patients with movement disorders

J. Khan, Z. Quamhawi, Y.F. Tai, P.G. Bain, D. Nandi, S. Gunning, N. Pavese (London, United Kingdom)

12:30pm-2:00pm: Cognitive outcome in the patients with Parkinson’s disease one year after subthalamic implants in Taiwan

Y.F. Chen, C.C. Chang, W.F. Chen, F.Y. Shih, M.Y. Lan, T.K. Lin, Y.F. Chen, Y.Y. Chang (Kaohsiung, Taiwan)

12:30pm-2:00pm: Comparing the characteristics of patients with Parkinson’s disease speech with and without deep brain stimulation

M.R. Olchik, A.L. Bressanelli, M. Presotto, A.F.S. Schuh, C.R.M. Rieder (Porto Alegre, Brazil)

12:30pm-2:00pm: Comparison of clinically derived and model based programming parameters of subthalamic nucleus stimulation in Parkinson’s disease

R. Reese, M.M. Reich, R. Nilunsing, W. Pollet, J. Volkmann (Würzburg, Germany)

12:30pm-2:00pm: Comparison of effect of variable deep brain stimulation (DBS) frequencies on gait and balance in Parkinson’s disease (PD) patients with either bilateral GPi or STN stimulators employing wearable wireless sensors

A. Deep, A. Lieberman, R. Dhall, T. Lockhart, C. Frames, S. Shafer, N. Tateuchi, E. Simpson, M. McCauley, N. Krishnamurthi (Phoenix, AZ, USA)

12:30pm-2:00pm: Comparison of four DBS lead designs under voltage and current operating modes based on patient specific simulations

F. Alonso, N. Göransson, P. Zsgimond, K. Wårdell (Linköping, Sweden)

12:30pm-2:00pm: Constant-current stimulation in Parkinson’s disease patients

P. Amami, M. Mascia, L. Romito, A. Albanese (Rozzano, Italy)

12:30pm-2:00pm: Cortical and subcortical contribution in the production of reaching movements in Parkinson’s disease

A. Canessa, N.G. Pozzi, G. Arnulfo, J. Brumberg, F. Steigerwald, M.F. Ghilardi, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)

12:30pm-2:00pm: DBS of the STN in 44 patients with Parkinson’s disease – Radiological and clinical outcome

R.C. Nickl, P. Fricke, S. Johannes, R.I. Ernestus, F. Steigerwald, M.M. Reich, V. Sturm, J. Volkmann, C. Matthies (Würzburg, Germany)

12:30pm-2:00pm: DBS programming requirements and longevity

M. Tagliati, E. Karst (Los Angeles, CA, USA)

12:30pm-2:00pm: DBS related on-state freezing of gait – A case series

Y.C. Tai, E. Everingham, D. Tsui, V. Fung, N. Mahant (Kaohsiung, Taiwan)

12:30pm-2:00pm: DBS targeting: Validation of 3T MR image guided targeting using post-mortem 17T MR microscopy

J.D. Hilliard, T. Morishita, C.H. Lee, S.J. Blackband, M.S. Okun, K.D. Foote (Gainesville, FL, USA)

12:30pm-2:00pm: Deep brain stimulation effect on the quality of life of individuals with Parkinson’s disease

A. Ayres, M. Ghisi, A.M. Freiry, B.S.F. Oliveira, A.F.S. Schuch, C.R.M. Rieder, M.R. Olchik (Porto Alegre, Brazil)

12:30pm-2:00pm: Deep brain stimulation in a Parkinsonian patient with sever psychiatric complication

T. Ichikawa, Y. Hashimoto, T. Obuchi, K. Kobayashi, H. Oshima (Ageo, Japan)

12:30pm-2:00pm: Deep brain stimulation in early stage Parkinson’s disease: Is it disease modifying?

M.L. Hacker, M. Turchan, J. Tonascia, P.E. Konrad, T.L. Davis, J.S. Neimat, F.T. Phibbs, A.L. Sternberg, D.M. Shade, L.T. Drye, D. Charles (Nashville, TN, USA)

12:30pm-2:00pm: Difference between physiologically defined subthalamic nucleus target and final lead placement: Influence in clinical outcome

A. Medina, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

12:30pm-2:00pm: Distribution of oscillatory activities in MRI confirmed subthalamic nucleus subregions

M. Beudel, A. Oswal, A. Jha, T. Foltynie, L. Zrinzo, M. Hariz, P. Limousin, S. Derrey, H. Akram, L. Vladimir, P. Brown (Groningen, Netherlands)

12:30pm-2:00pm: Does body mass index influence outcome of deep brain stimulation in Parkinson’s patients?

H. Abboud, G. Genc, D. Reyes, N.R. Thompson, R. Cerejo, K. Wilson, A. Ahmed, M. Gostkowski, A. Machado, H.H. Fernandez (Cleveland, OH, USA)

12:30pm-2:00pm: Effect of bilateral subthalamic nuclei deep brain stimulation on impulse control disorders in PD

R. Borgohain, P.K. Pesala, R.K. Mridula, A.K. Puligopu, V.V.P. Kagita, S.A. Jabeen, M.A. Kanikannan (Hyderabad, India)

12:30pm-2:00pm: Effect of frequency modulation on freezing of gait in PD patients after bilateral STN DBS

R.M. Kandadai, V.V.P. Kagita, S.A. Jabeen, A.K. Puligopu, M.A. Kanikannan, R. Borgohain (Hyderabad, India)

12:30pm-2:00pm: Effect of STN-DBS on impulse control disorder and affective behavioral complications of Parkinson’s disease: A 1-year longitudinal study

S.M. Omarova, N.V. Fedorova, E.V. Bril, A.A. Tomskiy, A.A. Gamaleya (Moscow, Russia)

12:30pm-2:00pm: Effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson’s disease: 7- year follow-up

G. Ehm, H.J. Kim, B.S. Jeon, D.G. Kim, S.H. Paek (Goyang, Korea)

12:30pm-2:00pm: Effectiveness and micro-electrodes findings of deep brain stimulation of the STN via a parietal approach in post-infectious previously implanted Parkinson´s patients

W.O. Contreras Lopez, L. Batista, A. Azevedo, M.J. Teixeira, E.T. Fonoff (São Paulo, Brazil)

12:30pm-2:00pm: Effects of subthalamic deep brain stimulation in motor and nonmotor function in Parkinson’s disease patients with parkin mutation

L.M. Oliveira, R.G. Cury, H.F. Chien, J.G. Santos, M.G. Ghilardi, R.B. Machado, E.T. Fonoff, B.R. Egberto (São Paulo, Brazil)

12:30pm-2:00pm: Efficacy of the bilateral subthalamic stimulation in Parkinson’s disease, results from the Neuromodulation Centre in Budapest

A. Kelemen, L. Eröss, D. Albert, I. Rózsa, E. Csibri, L. Entz, D. Fabó, L. Halász, G. Rudas, P. Barsi, P. Golopencza, G. Tamás (Budapest, Hungary)

12:30pm-2:00pm: Efficiency of intraoperative microelectrode recording in patients with deep brain stimulation of the subthalamic nucleus. Three-year comparative research

N. Gubareva, E. Bril, A. Tomskiy, N. Fedorova, S. Asriyants (Moscow, Russia)

12:30pm-2:00pm: Electric stimulation of the nucleus subthalamicus is able to modulate prepulse inhibition. A pilot study in Parkinson´s disease

J. Schuster, I. Galazky, M. Kühne, S. Specht, S. Nullmeier, H.J. Heinze, A. Kupsch, T. Zaehle, J. Voges, P. Panther (Magdeburg, Germany)

12:30pm-2:00pm: Electrophysiological activity of anatomically identified STN subterritories in Parkinson’s disease

N.G. Pozzi, G. Arnulfo, F. Steigerwald, A. Canessa, R. Nickl, C. Matthies, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)

12:30pm-2:00pm: Employing intraoperative microelectrode recordings during "asleep" deep brain stimulation surgery of the globus pallidus internus in Parkinson’s disease

J.E. Quintero, N.S. Timoney, J.H. Smith, F. McCarron, G.A. Gerhardt, C.G. van Horne (Lexington, KY, USA)

12:30pm-2:00pm: Evaluation of the accuracy of stereotactic DBS electrode implantation by post-operative image fusion

P. Fricke, S. Johannes, R. Nickl, R.I. Ernestus, F. Steigerwald, J. Volkmann, C. Matthies (Würzburg, Germany)

12:30pm-2:00pm: Face and color recognition after subthalamic nucleus stimulation in Parkinson’s disease

A. Gündüz, S. Yagci, S. Aydin, B.Ç. Poyraz, G. Genç, S. Oguz, H. Apaydin, G. Kiziltan, H. Hanagasi, M. Hanci, S. Ertan (Istanbul, Turkey)

12:30pm-2:00pm: How do patients experience deep brain stimulation surgery: A prospective patient satisfaction survey

A. Fazl, M. Gillego, A. Mogliner, M.H. Pourfar (New York, NY, USA)

12:30pm-2:00pm: How many and which kind of Parkinson’s disease patients need deep brain stimulation surgery? An evaluation based on clinical observation of patients with disease history of 15th year or more

H. Shibayama, T. Fukumoto, M. Tomura, K. Tokumoto, H. Yano, K. Tajima, F. Mitobe, F. Katada, S. Sato, T. Fukutake (Kamogawa City, Chiba, Japan)

12:30pm-2:00pm: Identification of unique metabolite signatures in post-mortem DBS human tissue using LC-HRMS

V. Vedam-Mai, S. Sternberg, M. Williams, T. Garrett, M.S. Okun (Gainesville, FL, USA)

12:30pm-2:00pm: Implantable pulse generator (IPG) longevity decreases following each replacement surgery in Parkinson’s disease (PD) patients treated with bilateral sub-thalamic nucleus deep brain stimulation (STN-DBS)

S.D. Israeli-Korn, S. Tessler, G. Yahalom, S. Benizri, O.S. Cohen, C. Shabat, H. Strauss, N. Warmann-Alaluf, E. Stein, Z. Zibly, R. Spiegelman, S. Hassin (Ramat Gan, Israel)

12:30pm-2:00pm: Improvement of impulse control disorder in Parkinson’s disease patients treated with subthalamic nucleus stimulation

E.J. Choi, J.K. Gu, D.G. Lee, S.M. Kim, J.K. Lee, C.S. Lee (Seoul, Korea)

12:30pm-2:00pm: Improving parkinsonism in DBS poor-responders by surgical lead revision of subthalamic electrodes

R.C. Nickl, M.M. Reich, S. Johannes, F. Steigerwald, P. Fricke, V. Sturm, R.I. Ernestus, J. Volkmann, C. Matthies (Würzburg, Germany)

12:30pm-2:00pm: In vivo validation of a new wireless portable stimulator for chronic deep brain stimulation in freely moving rats

F. Naudet, F. Kölbl, G. N'kaoua, E. Faggiani, B. Ribot, S. Renaud, N. Lewis, A. Benazzouz (Bordeaux, France)

12:30pm-2:00pm: Incidence and characteristics of gait dysfunction after subthalamic nucleus deep brain stimulation

V. Velez-Aldahondo, A.B. Millard, J.R. Jagid, C.C. Luca (Miami, FL, USA)

12:30pm-2:00pm: Is awake intraoperative mapping still necessary for bilateral subthalamic stimulation for Parkinson’s disease in a modern surgical environment?

Y. Zouitina, M. Lefranc, P. Merle, O. Godefroy, M. Tir, P. Krystkowiak (Amiens, France)

12:30pm-2:00pm: Is inter-limb coupling modified by subthalamic deep brain stimulation and dopaminergic medication in Parkinson’s disease?

C. Duval, J.F. Daneault, A.F. Sadikot (Montréal, QC, Canada)

12:30pm-2:00pm: Is the PPN a valuable target for deep brain stimulation in treatment of Parkinsonian disorders? Experience of a patient’s series

I. Galazky, A. Kupsch, E. Wirkus, F. Casjens, S. Specht, H.J. Heinze, J. Voges (Magdeburg, Germany)

12:30pm-2:00pm: Jaw opening dystonia and blepharospasm following bilateral VIM DBS for postural and action dystonic tremor

V. Paramanandam, D.A. Olszewska, C. Fearon, B. Magennis, B. Cheeran, T. Lynch (Dublin, Ireland)

12:30pm-2:00pm: Lead angle matters: Side effects of deep brain stimulation improved with adjustment of lead angle

M.H. Pourfar, A.Y. Mogilner (New York, NY, USA)

12:30pm-2:00pm: Longitudinal changes of speech and voice disorders following subthalamic stimulation in Parkinson’s disease patients

T. Tsuboi, H. Watanabe, Y. Tanaka, R. Ohdake, K. Kawabata, K. Hara, M. Ito, M. Hirayama, Y. Fujimoto, Y. Kajita, M. Katsuno, G. Sobue (Nagoya, Japan)

12:30pm-2:00pm: Measurement of effect of variable deep brain stimulation (DBS) frequencies on static postural control in Parkinson’s disease (PD) patients with bilateral STN or GPi stimulators by employing force plate

A. Deep, A. Lieberman, R. Dhall, T. Lockhart, S. Shafer, C. Frames, N. Tateuchi, E. Simpson, M. McCauley, N. Krishnamurthi, S. Syed (Phoenix, AZ, USA)

12:30pm-2:00pm: Minimal impact of “interleaving” on neuromodulation device battery drain when interleave frequency is halved

Y.M. Fernandez, D.L. Caputo, D.P. Schneider, S.F. Danish, R.J. Dipaola, E.L. Hargreaves (New Brunswick, NJ, USA)

12:30pm-2:00pm: Morbidity and comorbidity of deep brain stimulation for Parkinson’s disease – A thirteen-years retrospective cohort study

S.Y. Chen, Y.H. Pan, S.H. Lin (Hualien, Taiwan)

12:30pm-2:00pm: Mortality after deep brain stimulation surgery for patients with advanced Parkinson’s disease

H.S. Ryu, S. You, M.J. Kim, Y.J. Kim, J. Kim, K. Kim, S.J. Chung (Seoul, Korea)

12:30pm-2:00pm: MR-guided high intensity focused ultrasound in Parkinson’s disease: A series of 5 cases

N. Wegener, G. Kaegi, R. Bauer, B. Werner, E. Martin, S.R. Schreglmann, A. Lebeda, S. Haegele-Link (St. Gallen, Switzerland)

12:30pm-2:00pm: Multiple-source current steering in bilateral subthalamic nucleus deep brain stimulation for Parkinson’s disease: Our experience

J.M. Cardenas Prieto, P.A. Millan Giraldo (Cali, Colombia)

12:30pm-2:00pm: Neurophysiological assessment of corticospinal tract activation due to subthalamic deep brain stimulation in patients with Parkinson’s disease

P. Mahlknecht, H. Akram, D. Georgiev, J. Candelario, A. Zacharia, Z. Kefalopoulou, L. Zrinzo, J. Hyam, M. Hariz, C. Milabo, T. Foltynie, J.C. Rothwell, P. Limousin (Innsbruck, Austria)

12:30pm-2:00pm: Neuropsychological safety of bilateral pallidal (GPi) deep brain stimulation (DBS) for Parkinson’s disease (PD) under general anesthesia

A.I. Tröster, F.A. Ponce, L. Autry, M. Lambert, V.G. Evidente, S. Oravivattanakul, A. Lieberman, G. Moguel-Cobos, N. Salins, K. Hanson (Phoenix, AZ, USA)

12:30pm-2:00pm: Objectivisation of postural disorders in patients with Parkinson’s disease during the screening stage for DBS

A.G. Buniak, I.P. Maryenko, S.A. Likhachev (Minsk, Belarus)

12:30pm-2:00pm: Patient-centered outcomes of DBS in Parkinson’s disease

J. Karl, B. Ouyang, K. Colletta, L. Verhagen (Chicago, IL, USA)

12:30pm-2:00pm: Pisa syndrome in Parkinson’s disease effectively treated with subthalmic deep brain stimulation: Case report

C.A. Artusi, A. Romagnolo, M. Zibetti, M.G. Rizzone, A. Merola, F. Dematteis, M. Lanotte, L. Lopiano (Torino, Italy)

12:30pm-2:00pm: Quantification of tremor and rigidity during deep brain stimulation surgery for Parkison’s disease

P. Poortvliet, A. Fytagoridis, T. Coyne, P. Silburn (Brisbane, Australia)

12:30pm-2:00pm: Real-world safety of deep brain stimulation in patients with ≤7.5 years between disease onset and device implant

M.C. Schiess, L. Tonder, M. Wells, T. Weaver, V. Stoker (Houston, TX, USA)

12:30pm-2:00pm: Recharge frequency is not driven by therapy power usage in patients implanted with rechargeable deep brain stimulation systems

T. Weaver, P. Konrad, L. Timmerman, G. Molnar, K. Stromberg (Minneapolis, MN, USA)

12:30pm-2:00pm: Rechargeable pacemaker technology in deep brain stimulation: A step forward, but nor for everyone

J. Runge, A. Wloch, M. Abdallad, M. Manu, J.K. Krauss (Hannover, Germany)

12:30pm-2:00pm: Reduction in battery longevity for each subsequent implantable pulse generator (IPG) in patients with Parkinson’s disease (PD) treated with bilateral subthalamic nucleus deep brain stimulation (STN-DBS) may be due to both programming changes and IPG model – a case series

S.D. Israeli-Korn, S. Tessler, G. Yahalom, S. Benizri, O.S. Cohen, C. Shabat, H. Strauss, N. Warmann-Alaluf, E. Stein, Z. Zibly, R. Spiegelman, S. Hassin, S. Hassin (Ramat Gan, Israel)

12:30pm-2:00pm: Role of contact polarity on therapeutic impedances at two deep brain stimulation (DBS) targets

N. Bukhari, B.H. Kopell, R.A. Ramdhani (New York, NY, USA)

12:30pm-2:00pm: Single versus multiple microelectrode recordings (MER) in STN-DBS-surgery for PD: A randomized double-blind controlled trial

S. Bjerknes, A.E. Konglund, E. Ilstad, U. Pham, M. Skjelland, E. Dietrichs, M. Toft (Oslo, Norway)

12:30pm-2:00pm: Speech 10 years post bilateral STN-DBS for Parkinson’s disease

E. Tripoliti, P. Mahlknecht, L. Zrinzo, M. Hariz, T. Foltynie, J. Candelario, P. Limousin (London, United Kingdom)

12:30pm-2:00pm: Spinal cord stimulation improves freezing of gait in Parkinson’s disease in chronic implanted stn-dbs patients: A case report

C.O. Souza, C.P. Souza, A.L. Pardini, D. Boari, L.A. Teixeira, E.R. Barbosa, E.T. Fonoff (Sao Paulo, Brazil)

12:30pm-2:00pm: Stereotactic pallidotomy for Parkinson’s disease in El Salvador: One year follow up

S.L. Peña, R.E. Amaya (San Salvador, El Salvador)

12:30pm-2:00pm: Stimulation of the globus pallidus internus in the treatment of Parkinson’s disease: Long-term results of a monocentric follow-up

M.L. Lachenmayer, C. Bettschen, I. Debove, J. Muellner, C. Bernasconi, J.M. Burgunder, J.K. Krauss, M. Oertel, A. Kaelin, C. Pollo, M. Schuepbach (Bern, Switzerland)

12:30pm-2:00pm: Strengths and weaknesses of patient-reported outcomes following DBS surgery: Comparing clinician, patient, and caregiver assessments

L. Shahgholi, W. Deeb, K. Foote, A. Shukla, U. Akbar, J.P. Rossi, S. De Jesus, M.S. Okun (Gainesville, FL, USA)

12:30pm-2:00pm: Subthalamic nucleus deep brain stimulation modulate catecholamine levels with significant relations to clinical outcome after surgery in patients with Parkinson’s disease

T. Yamamoto, T. Uchiyama, Y. Higuchi, M. Asahina, S. Hirano, Y. Yamanaka, S. Kuwabara (Chiba, Japan)

12:30pm-2:00pm: Successful DBS: Doctors happy, patients not – Why?

M.H. Strothjohann, B. Holzinger, G.A. Fuchs, F. Weber (Bad Camberg, Germany)

12:30pm-2:00pm: Suggested protocol for electroconvulsive therapy for depression in a Parkinson’s disease patient with a deep brain stimulator: A case report

K. Dashtipour, M. Pereau, D. Trenkle, C. Osorio, K. Stoletniy (Loma Linda, CA, USA)

12:30pm-2:00pm: The core assessment program for surgical interventional therapies in Parkinson’s disease (CAPSIT-PD): Tolerability of preoperative neuropsychological testing for deep brain stimulation in Parkinson’s disease

G.D. Pal, V. Persinger, B. Bernard, B. Ouyang, C. Goetz, L. Verhagen (Chicago, IL, USA)

12:30pm-2:00pm: The effect of short pulse width neurostimulation in GPi-DBS

K. Kimura, H. Kishida, N. Ueda, K. Hamada, T. Kawasaki, F. Tanaka (Yokohama, Japan)

12:30pm-2:00pm: The effects of 60 Hz frequency of STN-DBS on gait in Parkinson’s disease

H. Brozová, K. Peterová, E. Ruzicka, J. Rusz, E. Plananská, L. Brabcová, R. Jech (Prague 2, Czech Republic)

12:30pm-2:00pm: The long-term follow-up of subthalamic nucleus deep brain stimulation comparing medication alone in advanced Parkinson’s disease patients

S.H. Lin, S.Y. Chen, F.S. Jaw (Hualien, Taiwan)

12:30pm-2:00pm: The study of clinical outcome of deep brain stimulation for the idiopathic Parkinson’s disease at 6 months follow-up

P. Papitak, M. Aphiwatthanakun, T. Srikijvilaikul, N. Limotai (Bangkok, Thailand)

12:30pm-2:00pm: The subthalamic nucleus activity during gait in Parkinson’s disease

A. Leporini, G. Arnulfo, N.G. Pozzi, C. Palmisano, J. Brumberg, A. Canessa, C.A. Frigo, G. Pezzoli, F. Steigerwald, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)

12:30pm-2:00pm: Toward clinical use of electrode localizations in deep brain stimulation therapy

S. Ewert, A. Horn, P. Plettig, M. Ruch, A. Kühn (Berlin, Germany)

12:30pm-2:00pm: Tractography patterns of subthalamic nucleus deep brain stimulation

N.S. Vanegas-Arroyave, P.M. Lauro, L. Huang, M. Hallett, S. Horovitz, K.A. Zaghloul, C. Lungu (New York, NY, USA)

12:30pm-2:00pm: Traditional trial-and-error versus neuroanatomical-3D-image software-assisted deep brain stimulation programming in patients with Parkinson’s disease

N. Pavese, S. Rodemark, Y.F. Tai, N. Yousif, D. Nandi, P.G. Bain (London, United Kingdom)

12:30pm-2:00pm: Transcranial unilateral MR guided high intensity focused ultrasound in Parkinson’s disease or essential tremor seems to be save concerning dysphagia and dysarthria

S. Hägele-Link, N.A. Wegener, S.R. Schreglmann, J. Rosenfeld, M. Mueller-Baumberger, R. Bauer, A. Lebeda, B. Werner, E. Martin, G. Kägi (St. Gallen, Switzerland)

12:30pm-2:00pm: Transient, symptomatic, non-infectious hypodensity around deep brain stimulation electrode

F. Alonso-Frech, J.A. Barcia Albacar, M.J. Catalán Alonso, C. Fernández, E. López Valdes, M. Yus (Madrid, Spain)

12:30pm-2:00pm: Two years after unilateral Forel’s H campotomy for Parkinson’s disease: Quality of life, motor and cognitive outcomes of eleven patients

F. Godinho, M.O. Oliveira, P. Terzian, C. Costa, P. Gordon, M.S. Rocha (São Paulo, Brazil)

12:30pm-2:00pm: Unilateral focused ultrasound thalamotomy in tremor-dominant Parkinson’s disease

B.B. Shah, D.S. Huss, S. Sperling, M.B. Harrison, J. Elias (Charlottesville, VA, USA)

12:30pm-2:00pm: Unilateral microelectrode mapping to guide bilateral deep brain stimulation electrode implantation: A retrospective study of anatomical lead placement and DBS programming outcomes

T.M. Herrington, K. Kanoff, J. Simon, E.N. Eskandar (Boston, MA, USA)

12:30pm-2:00pm: Upregulated vascular endothelial nitric oxide synthase in Parkinson’s disease cases that have received subthalamic stimulation: A post-mortem evaluation

C. Mantanona, L. Hodgson, J.L. Elson, I.S. Pienaar (Newcastle upon Tyne, United Kingdom)

12:30pm-2:00pm: Weight changes in PD patients post-DBS: A look at the factors involved

B. Ahmed, L.B. Almeida, A. Bona, S. De Jesus, D. Martinez-Ramirez, M.S. Okun (Gainesville, FL, USA)

« View all sessions from the 20th International Congress.